EGFR and lung carcinoma: Lung cancer is one of the most commonly diagnosed cancer and the leading cause of cancer deaths in both sexes combined [1], despite improvements in diagnosis and treatment, such as the emergence of immune checkpoint inhibitors, new-generation drugs (e.g. EGFR-TKI, ALK, eml4), and advanced radiotherapy technology.